Organization · Venture Capital
New Leaf Venture Partners
New Leaf Venture Partners is a New York-based venture capital firm that invests in early- to growth-stage healthcare and life sciences companies. The firm focuses on innovative healthcare solutions, including biopharmaceuticals and medical devices.
Overview
What New Leaf Venture Partners does
What New Leaf Venture Partners is
New Leaf Venture Partners is a New York-based venture capital firm that invests in early- to growth-stage healthcare and life sciences companies. The firm focuses on innovative healthcare solutions, including biopharmaceuticals and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2005
- Approximate age
- About 21 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find New Leaf Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
New Leaf Venture Partners as a funder
Investment thesis
New Leaf Venture Partners invests in healthcare technology companies that create clinically important and commercially attractive solutions, focusing on biopharmaceuticals, healthcare information convergence, and medical devices.
Focus narrative
New Leaf Venture Partners targets investments in healthcare-related companies, including biotechnology, pharmaceuticals, medical devices, and healthcare services. The firm emphasizes supporting companies that are innovating and addressing significant unmet medical needs.
Value beyond capital
New Leaf Venture Partners adds value to its portfolio companies through operational experience, advisory networks, and a focus on healthcare data and diagnostics. The firm emphasizes milestone-driven plans for value inflection and supports companies in navigating clinical and regulatory challenges.
Focus and fit
- Stages
- Friends and Family · Angel · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Sectors
- Biotech · Healthcare · Digital Health · Medical Devices · Pharma Tech · Health Data · Diagnostics
- Regions
- North America · Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include BrightInsight, a digital health platform for biopharma-compliant patient apps; Electra Therapeutics, a clinical-stage biotechnology company developing therapies for immune disorders; Star Therapeutics, focused on antibody therapeutics; and Flosonics Medical, which develops wearable ultrasound technology.
Common questions
What to know about New Leaf Venture Partners
Upseed classifies New Leaf Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.